GLAND Gland Pharma Ltd Major investments or disinvestments Announcement 2023 - US FDA Approval Gland Pharma Ltd received tentative approval from the US FDA for Angiotensin II Injection, with a potential 180 days of generic drug exclusivity..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Gland Pharma Ltd